• Nenhum resultado encontrado

Etofibrate but not controlled-release niacin decreases LDL cholesterol and lipoprotein (a) in type IIb dyslipidemic subjects

N/A
N/A
Protected

Academic year: 2019

Share "Etofibrate but not controlled-release niacin decreases LDL cholesterol and lipoprotein (a) in type IIb dyslipidemic subjects"

Copied!
6
0
0

Texto

Loading

Imagem

Table 1 - Baseline clinical characteristics.
Table 3 - Analysis of liver toxicity after treatment w ith etofibrate or niacin.

Referências

Documentos relacionados

Plasma levels of total cholesterol, HDLc, LDLc, triglycerides, lipoprotein(a), apolipoproteins AI, B and E, homocysteine, anti-oxidized LDL, high-sensitivity C-reactive

Figure 4.11 – Double layer capacitance as a function of the applied overpotential for HER on nickel electrodes (solid and mesh). Figure 4.12 – Inverse of charge

By using the Hellinger-Reissner variational principle (cf [ 8 , 24 ]), we proposed a stress and displacement- based element for finite strains which can be viewed as an exten- sion

METHODS: Based on the National Cholesterol Education Program, fasting lipoprotein levels and risk levels for coronary artery disease were determined in 28 patients with

Adjusted means for changes (%) in A, total cholesterol (TC); B, high-density lipoprotein cholesterol (HDL-C); C, low-density lipoprotein cholesterol (LDL-C), and D, log of

Our results show that supplementation of the two strains of Lactobacillus lowered serum total cholesterol levels, but low density lipoprotein (LDL) and triglyceride levels

Regarding the levels of cholesterol in the different lipoprotein fractions, the rats fed on a diet containing tambaqui fat had, statistically ( Table 5 ): (1) higher levels of

In boys, low intake of zinc was associated with elevated total cholesterol and triglyceride levels, whereas it was associated with low high-density lipoprotein cholesterol levels